MiniMedTM 780G insulin pump system ^
Automated for an
to stabilise glucose levels1,2,5
^ Components sold separately
Always Read the Instruction for Use. Medtronic's (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes. Guardian™ Sensor 3 may also be used as part of the MiniMed® 780G system^ for people living with Type 1 diabetes age 7 and up.
*Compared to the MiniMedTM 670G system. Refers to SmartGuardTM feature. Some user interaction required.
Individual results may vary.
less effort 24/71,2,3
less effort to keep low blood glucose from happening4
less effort to keep high blood glucose from happening4
Carb counting sucks
Nearly 50% of people with T1D consider counting carbohydrates as the most burdensome aspect of diabetes self-care.5
59% of people with T1D do not count meal carbohydrates correctly.6
for inaccurate carb count every 5 minutes if algorithm determines it's needed.1,2,3
SETTING YOUR GOALS
Only the MiniMedTM 780G system lets you set personal targets for your diabetes goals*.
* Refer to System User Guide
MiniMedTM 780G insulin pump system
90% of clinical trial patients agree the system is easy to use †
† Date on file from Protocol CH-1803-AHCL/Version 1.0: Pivotal Trial (Age 7-80) N=59. 2020; 2 NZ sites
1Accu-Check® Guide Link
Accurate test results from the blood glucose meter are sent wirelessly to the pump for quick sensor calibration.
2 Infusion set
Allows for continuous and discreet delivery of insulin.
3 Continuous Glucose Monitoring (CGM)
GuardianTM Sensor 3 measures sugar levels every 5 minutes sending info to the pump.
4 Smartphone Apps
Get notified of highs and lows with the MiniMedTM Mobile app. Care partners can download the CareLinkTM Connect app to stay in the know.
5 MiniMedTM 780G Insulin Pump
The waterproof2 pump receives info from the CGM to calculate insulin adjustments and corrections.
2At the time of manufacture and when the reservoir and tubing are properly inserted, your pump is waterproof. It is protected against the effects of being underwater to a depth of up to 12 feet (3.6 meters) for up to 24 hours. This is classified as IPX8 rating. See user guide for more details. The sensor and transmitter are water-resistant at 8 feet (2.4 meters) for up to 30 minutes. CGM reading may not be transmitted from the CGM to the pump while in water.
Insulin Pump Therapy
What is an insulin pump system?
An insulin pump is a small electronic device, about the size of a smartphone, that can be easily carried on a belt, inside a pocket, or attached to a bra and so virtually invisible to others.
It’s attached to your body via a thin tube called an infusion set, through which insulin is delivered. This makes insulin pump therapy very discreet.
When used with a CGM (continuous glucose monitor) it allows you to monitor sensor glucose levels in real time.
An insulin pump replaces the need for multiple injections by delivering rapid acting insulin continuously 24 hours a day. Our most advanced insulin pump system automatically adjusts and corrects insulin levels, for an easier* way to stabilise your glucose levels.1,2,3
Do I have to be connected 24/7?
The device is safe, and can be used in all types of situations (sport, beach, going out) and insulin is simply delivered to your body through a thin tube.
Thanks to smart accessories available today, it can be comfortably worn during school, exercise, formal occasions and everyday life.
Insulin pumps can be easily worn on or under your clothes very securely. The pump can also be detached for activities like swimming, showering and exercise so you can continue to live your life.
Will I be able to sleep comfortably?
The insulin pump therapy includes a CGM to help track in real time your glucose levels. This allows insulin pump therapy to understand your highs and lows and take corrective actions.
With MiniMedTM 780G system, 71% of clinical study participants report worrying less about lows during sleep.4
Do I get support from Medtronic?
Medtronic is changing the way people manage diabetes by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health. Medtronic does not only create innovative diabetes therapies solutions. With our products you also get access to:
Personalised onboarding program
Mobile phone app
(technical specialists & online reosurces)
1. Carlson, A.L. et al. 97-P- Safety and glycaemic outcomes of the MiniMed™ AHCL System in subjects with T1D. 80th ADA International Conference, June 2020, Chicago+E24
2. Collyns, O. et al. 199-OR- Improved glycaemic Outcomes with MiniMed™ AHCL Delivery. 80th ADA International Conference, June 2020, Chicago
3. Bergenstal, R. M. et al. Safety of a Hybrid-Closed Loop Insulin Delivery System in Patients with Type 1 Diabetes Jama. 2016; 316 (13): 1407 - 1408
4. Medtronic data on file. Pivotal trial (Age 14-75). N=157. 2020; 16 US sites
5. Medtronic data on file. 25-min survey, N=498 T1D individuals in Germany, Japan, US, Brazil, August 2019
6. Meade LT et al. Accuracy of Carbohydrate Counting in Adults. Clin Diabetes. 2016;34(3):142-147